Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. To illustrate this, consider that patent applications in the U.S.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MARCH 27, 2018

The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. He noted his agency’s “particular concerns in digital markets.” Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. In the U.S., ” How Data-opolies Harm.

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

FEBRUARY 2, 2015

Science and engineering professionals work closely with experienced technicians to produce next-generation batteries, not forged metal. Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. But just as U.S.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. telemetry, communications and connectivity protocols, electrical hardware engineering).

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

NOVEMBER 21, 2013

For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source. Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Why do some companies choose to patent their innovation while others choose to hide it? But there is a risk.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

JUNE 23, 2015

I studied cross-functional teams in industries including communications, software, pharmaceuticals, semiconductors, agricultural, chemical, manufacturers, retail, utility, consulting, internet software, government, insurance, and banking. Cross-functional teams have become ubiquitous because companies need to speed innovations to market.

Team 8

Team Project Software Engineering 8

Harvard Business Review

NOVEMBER 12, 2018

With dozens of other genetically engineered therapies moving through clinical trials, the long-promised era of personalized, gene-based medicine seemed to be at hand. ” As this first wave of genetic treatments hits the market, industry leaders face a stark choice. Creating better outcomes at reduced cost. New business models.

Business Model 10

Business Model Insurance Cost Bond 10

Harvard Business Review

NOVEMBER 27, 2013

Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. So it’s consistent with market forces. After the initial rush of enthusiasm and energy, established routines and networks can smother the drive for innovation.

CEO 13

CEO Long-term Welch Pharmaceuticals 13

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

MAY 7, 2015

Meanwhile, I had a lot friends and colleagues saying, “The capital markets are a huge problem.” My colleague Clayton Rose and I set out to discover whether the capital markets really are a problem, and we just couldn’t find much — or any — any evidence that this was true. Do the firms do better?

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

NOVEMBER 7, 2012

Innovation is one those evergreen themes: it is a rare CEO who doesn't list innovation as one her top four or five priorities. But innovation is an elusive beast. We can look to companies renowned for innovation — like Apple and Google — and try to learn from them. So what to do? But that's a flawed approach.

Company 8

Company Stage-Gate Innovation Bureaucracy 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. has become a Mecca for international scientists, engineers and business students — particularly those undertaking graduate studies.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

SEPTEMBER 5, 2016

Yet there’s compelling evidence that bureaucracy creates a significant drag on productivity and organizational resilience and innovation. More freedom and responsibility would mean more initiative, innovation, and institutional flexibility — which would further boost productivity. Here’s the arithmetic.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

SEPTEMBER 15, 2014

Consider Ashoka , which provides start-up funding and support for social innovators worldwide. As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. True, emerging market countries are getting better at what they do, and even Europe is on the upswing.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8